Intratumoral therapy with IL13-PE38 results in effective CTL-mediated suppression of IL-13Ralpha2-expressing contralateral tumors.

Source:http://linkedlifedata.com/resource/pubmed/id/16899618

Clin. Cancer Res. 2006 Aug 1 12 15 4678-86

Download in:

View as

General Info

PMID
16899618